glp-1 and binge eating disorder GLP-1RAs Obesity Associated with Disorders GLP-1 Agonist for Binge Eating

As clinical data and public discussion intersect, these launches are rewriting every rule in pharma marketing commanding broad consumer attention, setting new standards for adoption speed, and (perhaps most importantly) reshaping eXpectations around how life sciences brands engage, educate, and []

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fit uses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications

Discover what the evidence says about berberine, fibre, omega-3, and other natural compounds, plus important safety advice and when to see your GP.

Food intake was standardized, and blood samples were obtained every third hour

Designed for adults with obesity or those who are overweight with weight related health concerns